Page last updated: 2024-11-01

omeprazole and Parathyroid Neoplasms

omeprazole has been researched along with Parathyroid Neoplasms in 1 studies

Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.

Parathyroid Neoplasms: Tumors or cancer of the PARATHYROID GLANDS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sato, H1
Abe, K1
Oshima, N1
Kawashima, K1
Hamamoto, N1
Moritani, M1
Mak, R1
Ishihara, S1
Adachi, K1
Kawauchi, H1
Kinoshita, Y1

Other Studies

1 other study available for omeprazole and Parathyroid Neoplasms

ArticleYear
Primary hyperparathyroidism with duodenal ulcer and H. pylori infection.
    Internal medicine (Tokyo, Japan), 2002, Volume: 41, Issue:5

    Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenoma; Aged; Anti-Ulcer Agents; Benzimidazoles; Duodenal

2002